Verastem starts cancer trial in Japan
September 24, 2013 at 13:03 PM EDT
Verastem Inc. (Nasdaq: VSTM) has expanded its development reach to Japan with the beginning of an early-stage trial there of its lead candidate to treat mesothelioma...